| [1] |
Balcacer P, Shergill A, Litkouhi B. MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls[J]. Abdom Radiol (NY), 2019, 44(7): 2557-2571. DOI: 10.1007/s00261-019-01984-7.
|
| [2] |
Sung H, Ferlay J, Siegel RL, et al: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
|
| [3] |
Bhatla N, Berek JS, Cuello Fredes M, et al. Revised FIGO staging for carcinoma of the cervix uteri[J]. Int J Gynaecol Obstet, 2019, 145(1): 129-35.DOI： 10.1002/ijgo.12749.
|
| [4] |
Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri: 2021 update[J/OL]. Int J Gynaecol Obstet, 2021, 155 (Suppl 1): 28-44. DOI: 10.1002/ijgo.13865.
|
| [5] |
Salib M, Russell J, Stewart V, et al. 2018 FIGO staging classification for cervical cancer: added benefits of imaging[J]. Radiographics, 2020, 40(6)：1807-1822. DOI: 10.1148/rg.2020200013.
|
| [6] |
|
| [7] |
Woo S, Atun R, Ward ZJ, et al. Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and Meta-analysis[J]. Eur Radiol, 2020, 30(10): 5560-5577. DOI: 10.1007/s00330-020-06909-3.
|
| [8] |
Manganaro L, Lakhman Y, Bharwani N, et al. Staging, recurrence and follow-up of uterine cervical cancer using MRI: updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018[J]. Eur Radiol, 2021, 31(10): 7802-7816. DOI: 10.1007/s00330-020-07632-9.
|
| [9] |
Yang E, Huang S, Ran X, et al. The 5-year overall survival of cervical cancer in stage Ⅲ C-r was little different to stage Ⅰ and Ⅱ：a retrospective analysis from a single center[J]. BMC Cancer, 2021, 21(1): 203. DOI: 10.1186/s12885-021-07890-w.
|
| [10] |
|
| [11] |
Zhang W, Chen C, Liu P, et al. Impact of pelvic MRI in routine clinical practice on staging of Ⅰ B1-Ⅱ A2 cervical cancer[J]. Cancer Manag Res, 2019, 11: 3603-3609. DOI: 10.2147/CMAR.S197496.
|
| [12] |
Kraljević Z, Visković K, Ledinsky M, et al. Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings[J]. Coll Antropol, 2013, 37(2): 561-568.
|
| [13] |
Matsumoto YK, Kido A, Moribata Y, et al. Diagnostic accuracy of magnetic resonance imaging for International Federation of Gynecology and Obstetrics 2018 Ⅰ B to Ⅱ B Cervical Cancer Staging: comparison among magnetic resonance sequences and pathologies[J]. J Comput Assist Tomogr, 2021, 45(6): 829-836. DOI: 10.1097/RCT.0000000000001210.
|
| [14] |
Patel-Lippmann K, Robbins JB, Barroilhet L, et al. MR Imaging of cervical cancer[J]. Magn Reson Imaging Clin N Am, 2017, 25(3): 635-649. DOI: 10.1016/j.mric.2017.03.007.
|
| [15] |
|
| [16] |
Fournier LS, Bats AS, Durdux C. Diffusion MRI: technical principles and application to uterine cervical cancer[J]. Cancer Radiother, 2020, 24(5): 368-373. DOI: 10.1016/j.canrad.2020.02.008.
|
| [17] |
Liu L, Wang S, Yu T, et al. Value of diffusion-weighted imaging in preoperative evaluation and prediction of postoperative supplementary therapy for patients with cervical cancer[J]. Ann Transl Med, 2022, 10(2): 120. DOI: 10.21037/atm-21-5319.
|
| [18] |
Xiao M, Yan B, Li Y, et al. Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a Meta-analysis[J]. Eur Radiol, 2020, 30(3): 1405-1418. DOI: 10.1007/s00330-019-06461-9.
|
| [19] |
Song Q, Yu Y, Zhang X, et al. Value of MRI and diffusion-weighted imaging in diagnosing normal-sized pelvic lymph nodes metastases in patients with cervical cancer[J]. Br J Radiol, 2022, 95(1138): 20200203. DOI: 10.1259/bjr.20200203.
|
| [20] |
Takeuchi M, Matsuzaki K, Bando Y, et al. Reduced field-of-view diffusion-weighted MR imaging for assessing the local extent of uterine cervical cancer[J]. Acta Radiol, 2020, 61(2): 267-275. DOI: 10.1177/0284185119852733.
|
| [21] |
Takeuchi M, Matsuzaki K, Harada M. The feasibility of reduced field-of-view diffusion-weighted imaging in evaluating bladder invasion of uterine cervical cancer[J]. Br J Radiol, 2022, 95(1129): 20210692. DOI: 10.1259/bjr.20210692.
|
| [22] |
Boss MK, Muradyan N, Thrall DE. DCE-MRI: a review and applications in veterinary oncology[J]. Vet Comp Oncol, 2013, 11(2): 87-100. DOI: 10.1111/j.1476-5829.2011.00305.x.
|
| [23] |
Bhardwaj R, Boruah DK, Gogoi BB, et al. Added-value of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE-MRI) magnetic resonance imaging in the preoperative assessment of cervical cancer[J]. J Obstet Gynaecol India, 2022, 72(4): 330-340. DOI: 10.1007/s13224-021-01488-9.
|
| [24] |
Song J, Hu Q, Ma Z, et al. Value of diffusion-weighted and dynamic contrast-enhanced MR in predicting parametrial invasion in cervical stromal ring focally disrupted stage ⅠB-ⅡA cervical cancers[J]. Abdom Radiol (NY), 2019, 44(9): 3166-3174. DOI: 10.1007/s00261-019-02107-y.
|
| [25] |
Kim SH, Cho SH. Assessment of pelvic lymph node metastasis in FIGO IB and ⅡA cervical cancer using quantitative dynamic contrast-enhanced MRI parameters[J]. Diagn Interv Radiol, 2020, 26(5): 382-389. DOI: 10.5152/dir.2020.19365.
|
| [26] |
Bai Z, Shi J, Yang Z, et al. Quantitative kinetic parameters of primary tumor can be used to predict pelvic lymph node metastasis in early-stage cervical cancer[J]. Abdom Radiol (NY), 2021, 46(3): 1129-1136. DOI: 10.1007/s00261-020-02762-6.
|
| [27] |
Zhang X, Dong Y, Song Q, et al. The role of multiparametric magnetic resonance imaging in the study of primary tumor and pelvic lymph node metastasis in stage Ⅰ B1-Ⅱ A1 cervical cancer[J]. J Comput Assist Tomogr, 2020, 44(5): 750-758. DOI: 10.1097/RCT.0000000000001084.
|
| [28] |
Tian Y, Luo H. Diagnostic accuracy of transvaginal ultrasound examination for local staging of cervical cancer: a systematic review and meta-analysis[J]. Med Ultrason, 2022, 24(3): 348-355. DOI: 10.11152/mu-3246.
|
| [29] |
Zhu Y, Lu M, Dai KJ, et al. Comparison between 360 degrees 3-D transvaginal ultrasound and magnetic resonance imaging for assessment of vaginal invasion in cervical cancer: a preliminary report[J]. Ultrasound Med Biol, 2021, 47(8): 2250-2257. DOI: 10.1016/j.ultrasmedbio.2021.04.013.
|
| [30] |
Zhang HP, Bai M, Gu JY, et al. Value of contrast-enhanced ultrasound in the differential diagnosis of gallbladder lesion[J]. World J Gastroenterol, 2018, 24(6): 744-751. DOI: 10.3748/wjg.v24.i6.744.
|
| [31] |
Zheng W, Chen K, Peng C, et al. Contrast-enhanced ultrasonography vs MRI for evaluation of local invasion by cervical cancer[J]. Br J Radiol, 2018, 91(1091): 20170858. DOI: 10.1259/bjr.20170858.
|
| [32] |
Shao J, Shi G, Qi Z, et al. Advancements in the application of ultrasound elastography in the cervix[J]. Ultrasound Med Biol, 2021, 47(8): 2048-2063. DOI: 10.1016/j.ultrasmedbio.2021.04.009.
|
| [33] |
Zhang Y, Yan Y, Yang Y. Study on value of ultrasonic elastography in diagnosis of clinical staging of cervical cancer and efficacy evaluation of radiotherapy[J]. Oncol Lett, 2019, 17(6): 4901-4906. DOI: 10.3892/ol.2019.10190.
|
| [34] |
Farrokh A, Treu L, Ohlinger R, et al. A orospective two center study comparing breast cancer lesion size defined by 2D shear wave elastography, B-mode ultrasound, and mammography with the histopathological size[J]. Ultraschall Med, 2019, 40(2): 212-220. DOI: 10.1055/a-0661-5952.
|
| [35] |
Fu B, Zhang H, Song ZW, et al. Value of shear wave elastography in the diagnosis and evaluation of cervical cancer[J]. Oncol Lett, 2020, 20(3): 2232-2238. DOI: 10.3892/ol.2020.11759.
|
| [36] |
于甬华，于金明. 正电子发射型计算机断层显像在肿瘤临床中的应用[J]. 中华肿瘤杂志，2003, 25(6): 615-617.
|
| [37] |
Yang Z, Xu W, Ma Y, et al. (18)F-FDG PET/CT can correct the clinical stages and predict pathological parameters before operation in cervical cancer[J]. Eur J Radiol, 2016, 85(5): 877-884. DOI: 10.1016/j.ejrad.2016.02.010.
|
| [38] |
Martinez A, Voglimacci M, Lusque A, et al. Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer[J]. Eur J Nucl Med Mol Imaging, 2020, 47(5): 1252-1260. DOI: 10.1007/s00259-019-04659-z.
|
| [39] |
Tsuyoshi H, Tsujikawa T, Yamada S, et al. Diagnostic value of 18F-FDG PET/MRI for revised 2018 FIGO staging in patients with cervical cancer[J]. Diagnostics (Basel), 2021, 11(2): 202. DOI: 10.3390/diagnostics11020202.
|
| [40] |
Weissinger M, Taran FA, Gatidis S, et al. Lymph node staging with a combined protocol of 18F-FDG PET/MRI and sentinel node SPECT/CT: a prospective study in patients with FIGO Ⅰ/Ⅱ cervical carcinoma[J]. J Nucl Med, 2021, 62(8): 1062-1067. DOI: 10.2967/jnumed.120.255919.
|
| [41] |
|